HALO Macrodissection Solutions Brochure
Learn more about the automated workflow and benefits of HALO Macrodissection Solutions
HALO Macrodissection Solutions Brochure Read More »
HALO Macrodissection Solutions
Indica Labs Sets New Standard for Molecular Testing in Breast Cancer with Expansion of AI Macrodissection Portfolio
Albuquerque, NM, February 10, 2026 – Indica Labs, the world’s leading provider of AI-powered digital pathology solutions, today announced the expansion of its macrodissection portfolio with the launch of Breast Macrodissect AI . The suite now includes advanced algorithms for non-small cell lung cancer (NSCLC), colorectal cancer (CRC), and breast cancer, with prostate cancer planned for release in early 2026.
Indica Labs Expands their Macrodissection Suite with the Launch of CRC Macrodissect AI
Indica Labs, the leading provider of AI-powered digital pathology solutions, announces today the expansion of their macrodissection suite with the launch of CRC Macrodissect AI.
Indica Labs Expands their Macrodissection Suite with the Launch of CRC Macrodissect AI Read More »
Indica Labs Announces Launch of AI-Powered Macrodissection Suite to Advance Molecular Pathology Workflows
Albuquerque, NM – 1 August 2024 – Indica Labs, the leading provider of AI-powered digital pathology solutions, proudly announces the launch of Lung Macrodissect AI, a groundbreaking tool that revolutionizes slide macrodissection and molecular pathology workflows.